Díaz PH

Language: Spanish
References: 7
Page: 5-5
PDF size: 91.71 Kb.

Text Extraction

No abstract.

REFERENCES

1. Skiada A, Pavleas L, Drogari-Apiranthitou M. Epidemiologyand Diagnosis of Mucormycosis: An Update. JFungi (Basel) 2020; 6(4): 265-285.

2. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA,Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, etal. Mucormycosis ECMM MSG Global Guideline WritingGroup. Global guideline for the diagnosis and managementof mucormycosis: an initiative of the EuropeanConfederation of Medical Mycology in cooperation withthe Mycoses Study Group Education and ResearchConsortium. Lancet Infect Dis, 2019;19: e405-e421.

3. Corzo-León, D.E.; Chora-Hernández, L.D.; Rodríguez-Zulueta,A.P.; Walsh, T.J. Diabetes mellitus as the majorrisk factor for mucormycosis in Mexico: Epidemiology,diagnosis, and outcomes of reported cases. Med. Mycol.2018; 56: 29-43.

4. Walther, G.; Wagner, L.; Kurzai, O. Updates on the Taxonomyof Mucorales with an Emphasis on Clinically

5. Important Taxa. J. Fungi, 2019; 5: 106.Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A,Zaoutis T, Groll A, Lortholary A, Kontoyiannis DP, PetrikkosG. Development of new strategies for early diagnosisof mucormycosis from bench to bedside. Mycoses2014; 57(03): 2-7.

6. Dayal D, Bakshi J. Early Diagnosis and Surgery is Crucialto Survival Outcome in Rhinocerebral Mucormycosis.Indian J Otolaryngol Head Neck Surg 2016; 68: 261-262.

7. Trobisch A, Marterer R, Gorkiewicz G, Flaschberger S,Lackner H, Seidel M, Sperl DKarastaneva A, KohlmaierB, Egger M, Urban C, Benesch M, Strenger V. Invasivemucormycosis during treatment for acute lymphoblasticleukaemia—successful management of twolife-threatening diseases. Support Care Cancer. 2020;28: 2157-2161.